Hexaminolevulinate hydrochloride clinical trials
Also written Hexvix, hexaminolevulinate and Cysview.
How each study uses hexaminolevulinate hydrochloride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the hexaminolevulinate hydrochloride studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 28 May 2010 · CYSVIEW KIT · NDA 022555 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
20 studies that test it; most in 2009 (3)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2011 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 12 · Other 8
Photocure (11) · Joint Authority for Päijät-Häme Social and Health Care (1) · Oslo University Hospital (1) · Edward Messing (1) · Jørgen Bjerggaard Jensen (1) · Tongji Hospital (1) · Johns Hopkins University (1) · University of Roma La Sapienza (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test hexaminolevulinate hydrochloride, phase 3 first.
- Jan 2027Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light ResectionPhase 3 · Johns Hopkins University
Studies
Open first, then newest update. How each study uses hexaminolevulinate hydrochloride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 20
- Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light ResectionRecruitingPhase 3Johns Hopkins UniversityNCT06525571Written as CysviewHow we know
- Exploratory Study of the Efficacy of HAL-PDT in CIN 3Not yet recruitingPhase 2Tongji HospitalNCT07891338Written as Hexaminolevulinate (HAL)How we know
- Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)RecruitingPhase 4University of Roma La SapienzaNCT05962541Written as PDD-TURBT with hexaminolevulinate (Hexvix®)How we know
- Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder CancerCompletedPhase 3PhotocureNCT05600322Written as Hexaminolevulinate HydrochlorideHow we know
- Treatment of Female Genital Erosive Lichen Planus(GELP) With Hexaminolevulinate PDTCompletedPhase 2/3Oslo University HospitalNCT01282515Written as hexaminolevulinateHow we know
- The Correlation of Surgical Colorectal Cancer Specimen Pathology With the Fluorescence of Photodynamic DiagnosticsWithdrawnPhase 2Dr. Te VuongNCT03272659Written as CysviewHow we know
- Near Infrared Fluorescence Imaging for Bladder Cancer DetectionCompletedNot applicableEdward MessingNCT03058705Written as Hexaminolevulinate HCLHow we know
- Photodynamic Diagnosis (PDD) in Flexible CystoscopyCompletedPhase 3Jørgen Bjerggaard JensenNCT02660190Written as hexaminoavolunateHow we know
- Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MALActive, not recruitingPhase 1/2Joint Authority for Päijät-Häme Social and Health CareNCT02367547Written as Hexylaminolevulinate creamHow we know
- A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance SettingCompletedPhase 3PhotocureNCT02560584Written as Hexaminolevulinate hydrochlorideHow we know
- Recurrence of Bladder Cancer After Transurethral Resection With HexvixWithdrawnPhase 4GE HealthcareNCT00785694Written as hexaminolevulinateHow we know
- Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder CancerCompletedPhase 3PhotocureNCT00052637Written as hexaminolevulinateHow we know
- An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the ColonTerminatedPhase 1/2PhotocureNCT01344902Written as hexaminolevulinate HClHow we know
- Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence CystoscopyCompletedPhase 3PhotocureNCT00233402Written as HexvixHow we know
- A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder CancerCompletedPhase 3PhotocureNCT00412971Written as HexvixHow we know
- Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1TerminatedPhase 2PhotocureNCT00708942Written as Hexaminolevulinate (HAL)How we know
- Detection of Bladder Tumors After 30 Min Instillation of HexvixTerminatedPhase 2PhotocureNCT01551407Written as HexvixHow we know
- A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions.CompletedPhase 1/2PhotocureNCT00369018Written as methyl aminolevulinate (MAL) and hexaminolevulinate (HAL)How we know
- Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding StudyCompletedPhase 1/2PhotocureNCT00285701Written as hexaminolevulinateHow we know
- An Open-label, Single-dose, Three Period Study to Determine the Pharmacokinetic Parameters of Hexaminolevulinate (HAL) Hydrochloride After Vaginal, Enema and Intravenous Administration of Healthy Female VolunteersCompletedPhase 1PhotocureNCT01050309Written as hexaminolevulinate (HAL)How we know
What changed recently
From the registry's own updates since Oct 21, 2026.
Newly registered1
- Exploratory Study of the Efficacy of HAL-PDT in CIN 3Oct 23, 2026NCT07891338
Codes
What other systems call hexaminolevulinate hydrochloride · ClinicalTrials.gg INT004302
- MeSH (NLM) C4199245-aminolevulinic acid hexyl esterConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) D4F329SL1OHEXAMINOLEVULINATE HYDROCHLORIDEConfirmed FDA, Wikidata
- RxNorm 1426871Confirmed FDA, Wikidata
- Wikidata Q27276092hexaminolevulinate hydrochlorideConfirmed FDA, Wikidata
- NCI Thesaurus C73601Hexaminolevulinate HydrochlorideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C419924 | 5-aminolevulinic acid hexyl ester | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | D4F329SL1O | HEXAMINOLEVULINATE HYDROCHLORIDE | Confirmed FDA, Wikidata |
| RxNorm | 1426871 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27276092 | hexaminolevulinate hydrochloride | Confirmed FDA, Wikidata |
| NCI Thesaurus | C73601 | Hexaminolevulinate Hydrochloride | One source FDA |
Also registered as hexaminolevulinate (UNII G7H20TKI67 · RxNorm 1426872).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.